BIRC5 and cancer: Study in ovarian cancer cell lines (SKOV3 and OVCAR3 cells) has shown that the inhibition of BIRC5 gene by an inhibitor YM155 can significantly inhibit epithelial-mesenchymal transition (EMT) [7] to prevent cancer metastasis [9], which contributes to the treatment and prognosis of cancer patients [10, 11].